Description
MOTS-c at 40mg provides a complete 12-week supply at standard female dosing (5mg 3x/week = 15mg/week = ~12 weeks total from 40mg vial accounting for reconstitution losses). It is the preferred format for women committed to a full mitochondrial longevity protocol. MOTS-c’s effects are cumulative — AMPK sensitization improves progressively over 8–12 weeks of use, with insulin sensitivity improvements often measurable by week 4 and metabolic rate changes apparent by week 8.
The 40mg format also makes MOTS-c practical as part of a multi-peptide longevity stack. Stacked with NAD+ (AMPK and sirtuin activation together), SS-31 (mitochondrial membrane protection), and 5-Amino-1MQ (NNMT inhibition), MOTS-c forms a coherent mitochondrial longevity protocol that addresses energy production, membrane integrity, coenzyme availability, and metabolic efficiency simultaneously.
Female-calibrated dosing: 5–10mg subcutaneously 3x/week. The 40mg vial covers approximately 12 weeks at 5mg 3x/week. Administer in the morning or pre-exercise.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.






Reviews
There are no reviews yet.